Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)—A 6-Month Pilot Study of a Single Woman’s Experience Changes

Background and Objectives: Women with androgenic Polycystic Ovary Syndrome (PCOS) have increased endometrial cancer risk that cyclic progesterone will prevent; it may also reverse PCOS’s neuroendocrine origins. This pilot study’s purpose was to document 6-month experience changes in a woman with PCO...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirin, Sonia, Murray, Faye, Goshtasebi, Azita, Kalidasan, Dharani, Prior, Jerilynn C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538639/
https://www.ncbi.nlm.nih.gov/pubmed/34684061
http://dx.doi.org/10.3390/medicina57101024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538639/
https://www.ncbi.nlm.nih.gov/pubmed/34684061
http://dx.doi.org/10.3390/medicina57101024

Ejemplares similares